NCT03068624 2024-01-25
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
M.D. Anderson Cancer Center
Phase 1 Unknown
Clinical Trials
7 trialsNCT05088889 2023-11-28
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
Phase 1 Unknown
NCT02437279 2022-04-15
OpACIN
The Netherlands Cancer Institute
Phase 1 Unknown
NCT03784040 2019-04-08
da VINci
National University Hospital, Singapore
Phase 1 Unknown
NCT03527251 2018-05-30
SEQUENCE
Sun Yat-sen University
Phase 1 Unknown
NCT03098160 2017-10-30
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Threshold Pharmaceuticals
Phase 1 Unknown
NCT02608437 2015-11-18
NIBIT-M4
Italian Network for Tumor Biotherapy Foundation
Phase 1 Unknown